Which factors predict patient satisfaction with botulinum toxin treatment for cervical dystonia?
Objective: Investigate which factors influence patient satisfaction with botulinum neurotoxin type A (BoNT-A) treatment for cervical dystonia (CD) in routine practice. Background: We have previously…Development of a New Kinematic Model for Head and Neck Movement Assessment in Cervical Dystonia
Objective: The aim of this study is the development of a new kinematic model for cervical spine to assess abnormal head and neck postures and…Prevelance,clinical pathology and Treatment of Dystonia in Pakistani Population
Objective: Evaluate the gender,mean age,clinical spectrum and non–motor symptoms of the disease in Pakistan,a developing country of South East Asia. Background: Dystonia,a neurological syndrome,is characterized…NUBPL mutations cause combined dystonia with bilateral striatal necrosis and cerebellar atrophy
Objective: To elucidate the genetic cause of a distinct combined dystonia syndrome, inherited in an autosomal recessive fashion in a small UK kindred [Figure1A]. Background:…Clinical and electrophysiological features of seven patients with moving toes syndrome: Is it a type of spinal segmental myoclonus?
Objective: We aimed to present a case series of moving toes syndrome to show how clinical presentation and electrophysiological findings may change. Background: The moving…Management of fragility fractures in Parkinson’s Disease (PD)
Objective: To assess the management of osteoporotic fragility fractures in patients with PD attending a Movement disorders clinic. Background: Patients with PD have a high…End of Life Care in Parkinson’s Disease
Objective: We aim to identify the current practice at the Royal Devon & Exeter NHS trust of managing Patients with PD at the end of…Stiff-limb syndrome with cerebellar features and atypical EMG findings responds to IVIG
Objective: To describe a case of Stiff-Limb Syndrome with ataxic features which had delayed EMG findings and improvement to IVIG. Background: Stiff-Person Syndrome (SPS) is…Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: results from the Phase 3 study dose-titration phase
Objective: To determine the dose of APL-130277 required by each patient with Parkinson’s Disease (PD) to turn from OFF to Full ON. This dose is…Transcranial direct current stimulation enhances consolidation of learning in Parkinson’s disease
Objective: To examine the effects of training combined with transcranial direct current stimulation (tDCS) on writing performance and consolidation of learning in Parkinson’s disease (PD).…
- 1
- 2
- 3
- …
- 155
- Next Page »